Novel signatures of cancer-associated fibroblasts

International Journal of Cancer

Volumn 133, Issue 2, 2013, Pages 286-293

  Bozõky, Benedek ^a   Savchenko, Andrii ^a   Csermely, Péter ^b   Korcsmáros, Tamás ^b,c   Dúl, Zoltán ^b,c   Pontén, Fredrik ^d   Székely, Lászlõ ^a   Klein, George ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c EÖTVÖS LORÁND UNIVERSITY   (Hungary)

^d Rudbecklaboratoriet ^*  (Sweden)

Author keywords

cancer associated fibroblasts; myofibroblasts; Rho kinase; tumor microenvironment

Indexed keywords

PROTEIN ARHGAP26; PROTEIN ARHGAP31; PROTEIN AZI2; PROTEIN BHLHE40; PROTEIN DLG1; PROTEIN EGLN1; PROTEIN ITCH; PROTEIN PKM2; PROTEIN PLOD2; PROTEIN RAB31; PROTEIN RNF19A; PROTEIN ROCK2; RHO KINASE; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER ASSOCIATED FIBROBLAST; CANCER CELL; CANCER GROWTH; CELL TYPE; GENE PRODUCT; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MYOFIBROBLAST; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RNA ANALYSIS; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT;

CELL LINE, TUMOR; DATABASES, PROTEIN; FIBROBLASTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASMS; PHENOTYPE; RHO-ASSOCIATED KINASES; SIGNAL TRANSDUCTION;

EID: 84877815243     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28035     Document Type: Article

References (45)

1. Allen M, Louise Jones J,. Jekyll and Hyde: the role of the microenvironment on the progression of cancer. J Pathol 2011; 223: 162-76.
2. Elkabets M, Gifford AM, Scheel C, et al. Human tumors instigate granulin-expressing hematopoietic cells that promote malignancy by activating stromal fibroblasts in mice. Histopathology 2011; 121: 784-99.
3. Franco OE, Shaw AK, Strand DW, et al. Cancer associated fibroblasts in cancer pathogenesis. Semin Cell Dev Biol 2010; 21: 33-9.
4. Campbell I, Qiu W, Haviv I,. Genetic changes in tumour microenvironments. J Pathol 2011; 223: 450-8.
5. Stoker MG, Shearer M, O'Neill C,. Growth inhibition of polyoma-transformed cells by contact with static normal fibroblasts. J Cell Sci 1966; 1: 297-310.
6. Flaberg E, Markasz L, Petranyi G, et al. High-throughput live-cell imaging reveals differential inhibition of tumor cell proliferation by human fibroblasts. Int J Cancer 2011; 128: 2793-802.
7. Flaberg E, Guven H, Savchenko A, et al. The architecture of fibroblast monolayers of different origin differentially influences tumor cell growth. Int J Cancer 2012; 131: 2274-83.
8. Uhlén M, Björling E, Agaton C, et al. A human protein atlas for normal and cancer tissues based on antibody proteomics. Mol Cell Proteomics 2005; 4: 1920-32.
9. Uhlen M, Oksvold P, Fagerberg L, et al. Towards a knowledge-based Human Protein Atlas. Nat Biotechnol 2010; 28: 1248-50.
10. Boutet E, Lieberherr D, Tognolli M, et al. UniProtKB/Swiss-Prot: The Manually Annotated Section of the UniProt KnowledgeBase. Methods Mol Biol 2007; 406: 89-112.
11. Keshava Prasad TS, Goel R, Kandasamy K, et al. Human Protein Reference Database-2009 update. Nucleic Acids Res 2009; 37: D767-72.
12. Stark C, Breitkreutz B-J, Chatr-Aryamontri A, et al. The BioGRID Interaction Database: 2011 update. Nucleic Acids Res 2011; 39: D698-704.
13. Hildebrand JD, Taylor JM, Parsons JT, et al. An SH3 domain-containing GTPase-activating protein for Rho and Cdc42 associates with focal adhesion kinase. Mol Cell Biol 1996; 16: 3169-78.
14. Itoh RE, Kurokawa K, Ohba Y, et al. Activation of Rac and Cdc42 video imaged by fluorescent resonance energy transfer-based single-molecule probes in the membrane of living cells. Mol Cell Biol 2002; 22: 6582-91.
15. Tcherkezian J, Triki I, Stenne R, et al. The human orthologue of CdGAP is a phosphoprotein and a GTPase-activating protein for Cdc42 and Rac1 but not RhoA. Biol Cell 2006; 98: 445-56.
16. Burridge K, Wennerberg K,. Rho and Rac take center stage. Cell 2004; 116: 167-79.
17. Hall A,. Rho GTPases and the control of cell behaviour. Biochem Soc Trans 2005; 33: 891-5.
18. Van Aelst L, D'Souza-Schorey C,. Rho GTPases and signaling networks. Genes Dev 1997; 11: 2295-322.
19. Carr HS, Cai C, Keinänen K, et al. Interaction of the RhoA exchange factor Net1 with discs large homolog 1 protects it from proteasome-mediated degradation and potentiates Net1 activity. J Biol Chem 2009; 284: 24269-80.
20. Samuel MS, Lopez JI, McGhee EJ, et al. Actomyosin-mediated cellular tension drives increased tissue stiffness and β-catenin activation to induce epidermal hyperplasia and tumor growth. Cancer Cell 2011; 19: 776-91.
21. Epstein ACR, Gleadle JM, Mcneill LA, et al. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 2001; 107: 43-54.
22. Ivan M, Haberberger T, Gervasi DC, et al. Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor. Proc Natl Acad Sci USA 2002; 99: 13459-64.
23. Bai Y, Yang C, Hu K, et al. Itch E3 Ligase-mediated regulation of TGF-beta signaling by modulating Smad2 phosphorylation. Mol Cell 2004; 15: 825-31.
24. Marchese A, Raiborg C, Santini F, et al. The E3 ubiquitin ligase AIP4 mediates ubiquitination and sorting of the G protein-coupled receptor CXCR4. Dev Cell 2003; 5: 709-22.
25. Niwa J, Ishigaki S, Doyu M, et al. A novel centrosomal ring-finger protein, dorfin, mediates ubiquitin ligase activity. Biochem Biophys Res Commun 2001; 281: 706-13.
26. Hathurusinghe HR, Goonetilleke KS, Siriwardena AK,. Current status of tumor M2 pyruvate kinase (tumor M2-PK) as a biomarker of gastrointestinal malignancy. Ann Surg Oncol 2007; 14: 2714-20.
27. Christofk HR, Vander Heiden MG, Harris MH, et al. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 2008; 452: 230-3.
28. Steták A, Veress R, Ovádi J, et al. Nuclear translocation of the tumor marker pyruvate kinase M2 induces programmed cell death nuclear translocation of the tumor marker pyruvate kinase. 2007; 67: 1602-8.
29. Chiavarina B, Whitaker-menezes D, Martinez-outschoorn UE, et al. Pyruvate kinase expression (PKM1 and PKM2) in cancer-associated fibroblasts drives stromal nutrient production and tumor growth. Cancer Biol Ther 2012; 12: 1101-13.
30. Fujita F, Taniguchi Y, Kato T, et al. Identification of NAP1, a Regulatory Subunit of IκB kinase-related kinases that potentiates NF-κB signaling. Mol Cell Biol 2003; 23: 7780-93.
31. Sasai M, Oshiumi H, Matsumoto M, et al. NF kappa B-activating kinase-associated protein 1 participates in TLR3/Toll-IL-1 homology domain-containing adapter molecule-1-mediated IFN regulatory factor 3 activation. J Immunol 2005; 174: 27-30.
32. Li Y, Zhang H, Xie M, et al. Abundant expression of Dec1/stra13/sharp2 in colon carcinoma: its antagonizing role in serum deprivation-induced apoptosis and selective inhibition of procaspase activation. Biochem J 2002; 367: 413-22.
33. Chakrabarti J, Turley H, Campo L, et al. The transcription factor DEC1 (stra13, SHARP2) is associated with the hypoxic response and high tumour grade in human breast cancers. Br J Cancer 2004; 91: 954-8.
34. Guillaumond F, Lacoche S, Dulong S, et al. Altered Stra13 and Dec2 circadian gene expression in hypoxic cells. Biochem Biophys Res Commun 2008; 369: 1184-9.
35. Noshiro M, Usui E, Kawamoto T, et al. Liver X receptors (LXRalpha and LXRbeta) are potent regulators for hepatic Dec1 expression. Genes Cells 2009; 14: 29-40.
36. Sato F, Bhawal UK, Kawamoto T, et al. Basic-helix-loop-helix (bHLH) transcription factor DEC2 negatively regulates vascular endothelial growth factor expression. Genes Cells 2008; 13: 131-44.
37. Lennon DP, Edmison JM, Caplan AI,. Cultivation of rat marrow-derived mesenchymal stem cells in reduced oxygen tension: effects on in vitro and in vivo osteochondrogenesis. J Cell Physiol 2001; 187: 345-55.
38. Yun Z, Maecker HL, Johnson RS, et al. Inhibition of PPAR gamma 2 gene expression by the HIF-1-regulated gene DEC1/Stra13: a mechanism for regulation of adipogenesis by hypoxia. Dev Cell 2002; 2: 331-41.
39. Ruotsalainen H, Vanhatupa S, Tampio M, et al. Complete genomic structure of mouse lysyl hydroxylase 2 and lysyl hydroxylase 3/collagen glucosyltransferase. Matrix Biol 2001; 20: 137-46.
40. van der Slot AJ, Zuurmond A-M, Bardoel AFJ, et al. Identification of PLOD2 as telopeptide lysyl hydroxylase, an important enzyme in fibrosis. J Biol Chem 2003; 278: 40967-72.
41. Noda T, Yamamoto H, Takemasa I, et al. PLOD2 induced under hypoxia is a novel prognostic factor for hepatocellular carcinoma after curative resection. Liver Int 2012; 32: 110-8.
42. Zhao X-H, Laschinger C, Arora P, et al. Force activates smooth muscle alpha-actin promoter activity through the Rho signaling pathway. J Cell Sci 2007; 120: 1801-9.
43. Egeblad M, Rasch MG, Weaver VM,. Dynamic interplay between the collagen scaffold and tumor evolution. Curr Opin Cell Biol 2010; 22: 697-706.
44. Smoot ME, Ono K, Ruscheinski J, et al. Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics (Oxford, England) 2011; 27: 431-2.
45. Boyle EI, Weng S, Gollub J, et al. GO::TermFinder-open source software for accessing Gene Ontology information and finding significantly enriched Gene Ontology terms associated with a list of genes. Bioinformatics (Oxford, England) 2004; 20: 3710-5.